Hexadecafluoroctamethylen-diisocyanat | 13044-45-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Hexadecafluoroctamethylen-diisocyanat
• 英文别名: Hexadecafluorooctamethylene diisocyanate；1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluoro-1,8-diisocyanatooctane
• CAS: 13044-45-6
• 化学式: C₁₀F₁₆N₂O₂
• 分子量: 484.097
• InChiKey: YBHXLBIQJGHDJU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  30
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  58.9
• 氢给体数：
  0
• 氢受体数：
  20

反应信息

• 作为反应物：
  描述：

  Hexadecafluoroctamethylen-diisocyanat 、 苯甲醇 以 乙醚 为溶剂， 生成 Hexadodecafluoroctamethylen-dibenzylurethan
  参考文献：
  名称：

  Perfluorodiisocyanates

  摘要：

  DOI：

  10.1007/bf00846076
• 作为产物：
  描述：

  hexadecafluoro-decanedioyl dichloride 生成 Hexadecafluoroctamethylen-diisocyanat
  参考文献：
  名称：

  Perfluorodiisocyanates

  摘要：

  DOI：

  10.1007/bf00846076

文献信息

• SEALING AGENT FOR GENITALS
  申请人：Sanyo Chemical Industries, Ltd.

  公开号：EP3620187A1

  公开（公告）日：2020-03-11

  The present invention aims to provide a cervical canal sealant that can be used as a sealant to stop bleeding in the uterus and vaginal discharge, particularly, a cervical canal sealant that can block the cervical canal to inhibit amniotic fluid leakage and that can also be peeled off without damaging reproductive tissue. The present invention relates to a sealant for reproductive organs in which a cured product (X) at 25°C has a storage modulus G' of 200 to 2,000 kPa, the cured product (X) being a cured product obtained by curing the sealant for reproductive organs to a thickness of 120 to 150 µm.

  本发明的目的是提供一种宫颈管密封剂，它可以用作子宫出血和阴道分泌物止血的密封剂，特别是一种可以堵塞宫颈管以抑制羊水渗漏，并且还可以在不损伤生殖组织的情况下剥离的宫颈管密封剂。本发明涉及一种生殖器官密封剂，其中固化产品（X）在 25°C 时的储存模量 G' 为 200 至 2,000 千帕，固化产品（X）是将生殖器官密封剂固化到 120 至 150 微米厚度后得到的固化产品。
• MEDICAL ADHESIVE
  申请人：Kawakami Naoaki

  公开号：US20140018510A1

  公开（公告）日：2014-01-16

  The present invention is directed to providing a safe medical adhesive, a cured body of which is hard to be degraded and decomposed and thus stable and the cured body generates less amount of acid, aldehyde, etc. due to degradation/decomposition. The medical adhesive includes a hydrophilic urethane prepolymer (UP) obtained by reacting a polyisocyanate component (A) containing a fluorine-containing non-aromatic polyisocyanate compound (A1) as an essential ingredient and a polyol component (B) containing a hydrophilic polyol (B1) as an essential ingredient, wherein a chlorine content in a chlorine-containing organic compound based on the weight of the hydrophilic urethane prepolymer (UP) is 0.005 wt % or less.
• US9421299B2
  申请人：——

  公开号：US9421299B2

  公开（公告）日：2016-08-23